Background There is increasing evidence of therapeutic benefits from bone marrow (BM)-
derived mesenchymal stromal cells (MSC) in various animal models with neurologic …

OBJECTIVE: This study was designed to investigate the effects of intracerebral as well as
intravenous administration of bone marrow stromal cells (MSCs) on endogenous cellular …

OBJECTIVE We investigated the effect of human bone marrow stromal cells (hMSCs)
administered intravenously on functional outcome after traumatic brain injury in adult rats …

OBJECTIVE: This study was designed to investigate the effects of human bone marrow
stromal cell (hMSC) administration in rats for 3 months after traumatic brain injury (TBI) …

There is a paucity of therapies for most central nervous system (CNS) disorders. Bone
marrow stromal cells (MSCs) are a mixed cell population, including stem and progenitor …

Transplantation of bone marrow-derived mesenchymal stromal cells (MSCs) into the injured
brain or spinal cord may provide therapeutic benefit. Several models of central nervous …

This study was designed to investigate the potential beneficial effects of bone marrow
stromal cell (MSC) treatment of traumatic brain injury (TBI) in mice. Twelve female C57BL/6J …

Object Cell therapy has shown preclinical promise in the treatment of many diseases, and its
application is being translated to the clinical arena. Intravenous mesenchymal stem cell …

There has been a growing interest in the use of stem cells in medical treatment because of
their capacity to generate cell types into multiple lineages, including neural tissue [1]. Neural …

Accumulated evidence suggests that bone marrow stromal cells (BMSCs) are capable of
regenerating damaged tissue. This study evaluated whether intravenously (noninvasively) …